These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

489 related articles for article (PubMed ID: 19429401)

  • 41. Perfluorooctanesulfonate and related fluorochemicals in human blood from several countries.
    Kannan K; Corsolini S; Falandysz J; Fillmann G; Kumar KS; Loganathan BG; Mohd MA; Olivero J; Van Wouwe N; Yang JH; Aldoust KM
    Environ Sci Technol; 2004 Sep; 38(17):4489-95. PubMed ID: 15461154
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Concentrations of perfluoroalkyl compounds in maternal and umbilical cord sera and birth outcomes in Korea.
    Lee YJ; Kim MK; Bae J; Yang JH
    Chemosphere; 2013 Feb; 90(5):1603-9. PubMed ID: 22990023
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Consumption of seafood, serum liver enzymes, and blood levels of PFOS and PFOA in the Japanese population.
    Yamaguchi M; Arisawa K; Uemura H; Katsuura-Kamano S; Takami H; Sawachika F; Nakamoto M; Juta T; Toda E; Mori K; Hasegawa M; Tanto M; Shima M; Sumiyoshi Y; Morinaga K; Kodama K; Suzuki T; Nagai M; Satoh H
    J Occup Health; 2013; 55(3):184-94. PubMed ID: 23574777
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Serum levels of perfluorooctanoic acid and perfluorooctane sulfonate and pregnancy outcome.
    Stein CR; Savitz DA; Dougan M
    Am J Epidemiol; 2009 Oct; 170(7):837-46. PubMed ID: 19692329
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prenatal perfluoroalkyl substances and newborn anogenital distance in a Canadian cohort.
    Arbuckle TE; MacPherson S; Foster WG; Sathyanarayana S; Fisher M; Monnier P; Lanphear B; Muckle G; Fraser WD
    Reprod Toxicol; 2020 Jun; 94():31-39. PubMed ID: 32283250
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Neonatal-maternal factors and perfluoroalkyl substances in cord blood.
    Lien GW; Huang CC; Wu KY; Chen MH; Lin CY; Chen CY; Hsieh WS; Chen PC
    Chemosphere; 2013 Aug; 92(7):843-50. PubMed ID: 23689097
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Perfluorooctane sulfonate (PFOS) and related perfluorinated compounds in human maternal and cord blood samples: assessment of PFOS exposure in a susceptible population during pregnancy.
    Inoue K; Okada F; Ito R; Kato S; Sasaki S; Nakajima S; Uno A; Saijo Y; Sata F; Yoshimura Y; Kishi R; Nakazawa H
    Environ Health Perspect; 2004 Aug; 112(11):1204-7. PubMed ID: 15289168
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Serum levels of perfluoroalkyl acids (PFAAs) with isomer analysis and their associations with medical parameters in Chinese pregnant women.
    Jiang W; Zhang Y; Zhu L; Deng J
    Environ Int; 2014 Mar; 64():40-7. PubMed ID: 24361923
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Human serum levels of perfluorooctane sulfonate (PFOS) and perfluorooctanoate (PFOA) in Uyghurs from Sinkiang-Uighur Autonomous Region, China: background levels study.
    Zeng XW; Qian Z; Vaughn M; Xian H; Elder K; Rodemich E; Bao J; Jin YH; Dong GH
    Environ Sci Pollut Res Int; 2015 Mar; 22(6):4736-46. PubMed ID: 25339531
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effect of perfluoroalkyl exposure in pregnancy and infancy on intrauterine and childhood growth and anthropometry. Sub study from COPSAC2010 birth cohort.
    Sevelsted A; Gürdeniz G; Rago D; Pedersen CT; Lasky-Su JA; Checa A; Zhang P; Wheelock CE; Normann SS; Kristensen DM; Rasmussen MA; Schullehner J; Sdougkou K; Martin JW; Stokholm J; Bønnelykke K; Bisgaard H; Chawes B
    EBioMedicine; 2022 Sep; 83():104236. PubMed ID: 36030647
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Concentrations of persistent organic pollutants in maternal and cord blood from the maternal-infant research on environmental chemicals (MIREC) cohort study.
    Fisher M; Arbuckle TE; Liang CL; LeBlanc A; Gaudreau E; Foster WG; Haines D; Davis K; Fraser WD
    Environ Health; 2016 May; 15(1):59. PubMed ID: 27142700
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Maternal exposure to perfluorinated acids and fetal growth.
    Hamm MP; Cherry NM; Chan E; Martin JW; Burstyn I
    J Expo Sci Environ Epidemiol; 2010 Nov; 20(7):589-97. PubMed ID: 19865074
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Relationships of perfluorooctanoate and perfluorooctane sulfonate serum concentrations between mother-child pairs in a population with perfluorooctanoate exposure from drinking water.
    Mondal D; Lopez-Espinosa MJ; Armstrong B; Stein CR; Fletcher T
    Environ Health Perspect; 2012 May; 120(5):752-7. PubMed ID: 22271837
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prenatal exposure to perfluoroalkyl substances, immune-related outcomes, and lung function in children from a Spanish birth cohort study.
    Manzano-Salgado CB; Granum B; Lopez-Espinosa MJ; Ballester F; Iñiguez C; Gascón M; Martínez D; Guxens M; Basterretxea M; Zabaleta C; Schettgen T; Sunyer J; Vrijheid M; Casas M
    Int J Hyg Environ Health; 2019 Jul; 222(6):945-954. PubMed ID: 31262703
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Serum perfluorooctanoate (PFOA) and perfluorooctane sulfonate (PFOS) concentrations and liver function biomarkers in a population with elevated PFOA exposure.
    Gallo V; Leonardi G; Genser B; Lopez-Espinosa MJ; Frisbee SJ; Karlsson L; Ducatman AM; Fletcher T
    Environ Health Perspect; 2012 May; 120(5):655-60. PubMed ID: 22289616
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prenatal exposure to perfluorooctanoate (PFOA) and perfluorooctanesulfonate (PFOS) and maternally reported developmental milestones in infancy.
    Fei C; McLaughlin JK; Lipworth L; Olsen J
    Environ Health Perspect; 2008 Oct; 116(10):1391-5. PubMed ID: 18941583
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The Association of Prenatal Exposure to Perfluorinated Chemicals with Glucocorticoid and Androgenic Hormones in Cord Blood Samples: The Hokkaido Study.
    Goudarzi H; Araki A; Itoh S; Sasaki S; Miyashita C; Mitsui T; Nakazawa H; Nonomura K; Kishi R
    Environ Health Perspect; 2017 Jan; 125(1):111-118. PubMed ID: 27219028
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Historical human exposure to perfluoroalkyl acids in the United States and Australia reconstructed from biomonitoring data using population-based pharmacokinetic modelling.
    Gomis MI; Vestergren R; MacLeod M; Mueller JF; Cousins IT
    Environ Int; 2017 Nov; 108():92-102. PubMed ID: 28818713
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Hazard quotient profiles used as a risk assessment tool for PFOS and PFOA serum levels in three distinctive European populations.
    Ludwicki JK; Góralczyk K; Struciński P; Wojtyniak B; Rabczenko D; Toft G; Lindh CH; Jönsson BA; Lenters V; Heederik D; Czaja K; Hernik A; Pedersen HS; Zvyezday V; Bonde JP
    Environ Int; 2015 Jan; 74():112-8. PubMed ID: 25454227
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Background levels of persistent organic pollutants in humans from Taiwan: perfluorooctane sulfonate and perfluorooctanoic acid.
    Hsu JY; Hsu JF; Ho HH; Chiang CF; Liao PC
    Chemosphere; 2013 Sep; 93(3):532-7. PubMed ID: 23886440
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.